Contract facts
NONENo full NAICS 541714 intel page yet. Browse NAICS intelligence
VENATORX PHARMACEUTICALS: NEW ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE BACTERIA INCLUDING PUBLIC HEALTH PATHOG… is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by Venatorx Pharmaceuticals Inc. Estimated value $45.2M ($45.2M obligated). Current period of performance ends Dec 31, 2027 (potential Dec 31, 2029). Last award drew 1 bidder. Place of performance: MALVERN, PA. Related solicitation BAA18100SOL00003.
VENATORX PHARMACEUTICALS: NEW ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE BACTERIA INCLUDING PUBLIC HEALTH PATHOGENS.
Recompete timing
PublicCurrent PoP ends Dec 31, 2027 (481 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.
Incumbent footprint
Public recordVenatorx Pharmaceuticals Inc — $44.4M obligated across 6 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75A50123C00050?
75A50123C00050 (Venatorx pharmaceuticals: NEW antibiotics to) is a Barda - Aspr / Daappo / Barda Dcma award with an estimated value of $45.2M, currently held by Venatorx Pharmaceuticals Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75A50123C00050?
Barda - Aspr / Daappo / Barda Dcma awarded 75A50123C00050 to Venatorx Pharmaceuticals Inc.
Who is the incumbent on 75A50123C00050?
Venatorx Pharmaceuticals Inc is the incumbent with $44.4M across 6 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2027.
When does Venatorx Pharmaceuticals Inc’s 75A50123C00050 come up for recompete?
SCOUT tracks a period-of-performance end of Dec 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Seen enough? Run one full capture cycle on 75A50123C00050 — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.